Aspirin Shows No Survival Benefit in Colorectal Cancer Treatment

Exploring the Role of Aspirin in Post-Treatment Outcomes for Colorectal Cancer Patients

Jan 17, 2025

∙ Paid

A clean, modern medical illustration depicting colorectal cancer research. The image features a symbolic representation of the colon with simplified, clear anatomy, paired with icons of aspirin tablets to indicate treatment. A subtle DNA strand is integrated into the background, symbolizing innovation and research. The design is professional, approachable, and emphasizes clarity and positivity, with soft blue and green tones to convey hope and health. The overall style is minimalistic and visually appealing, suitable for a scientific article on colorectal cancer treatment advancements.

Topline

The ASCOLT trial found that aspirin, at a daily dose of 200 mg, did not significantly improve disease-free survival (DFS) or overall survival (OS) in patients with colorectal cancer following standard adjuvant therapy.

Study Details

Colorectal cancer (CRC) remains a leading cause of cancer-related deaths globally. Aspirin, a well-known anti-inflamm…

Continue reading this post for free, courtesy of Naveen Sankar S.

Or purchase a paid subscription.

Just Healthcare

Aspirin Shows No Survival Benefit in Colorectal Cancer Treatment

Exploring the Role of Aspirin in Post-Treatment Outcomes for Colorectal Cancer Patients

Topline

Study Details

Continue reading this post for free, courtesy of Naveen Sankar S.